Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis

Clinical Microbiology and Infection

Volumn 17, Issue 5, 2011, Pages 780-784

  Tsai, H C ^a,b   Shi, M H ^a,b   Lee, S S J ^a,b   Wann, S R ^a,b   Tai, M H ^c   Chen, Y S ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Matrix metalloproteinase; Meningitis; Tissue inhibitors of matrix metalloproteinase; Zymography

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; PRIORITY JOURNAL; ZYMOGRAPHY;

BACTERIA (MICROORGANISMS);

EID: 79955382629     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03393.x     Document Type: Article

References (29)

1. Lu CH, Chang WN, Chang HW. Adult bacterial meningitis in Southern Taiwan: epidemiologic trend and prognostic factors. J Neurol Sci 2000; 182: 36-44.
2. Lu CH, Chang WN, Chuang YC, Chang HW. The prognostic factors of adult gram-negative bacillary meningitis. J Hosp Infect 1998; 40: 27-34.
3. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21: 243-261.
4. Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 2007; 4: e21.
5. Leppert D, Leib SL, Grygar C, Miller KM, Schaad UB, Holländer GA. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 2000; 31: 80-84.
6. Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 2001; 36: 249-257.
7. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinease B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002; 37: 375-536.
8. Tsai HC, Liu SF, Wu KS et al. Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis. Inflammation 2008; 31: 247-253.
9. Tsai HC, Chung LY, Chen ER et al. Association of MMP-9 and TIMP-4 in CSF with blood brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis. Am J Trop Med Hyg 2008; 78: 20-27.
10. Latronico T, Liuzzi GM, Riccio P et al. Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients. AIDS 2007; 21: 677-684.
11. Fang CT, Chen YC, Chang SC, Sau WY, Luh KT. Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM 2000; 93: 45-53.
12. Sheu JJ, Yuan RY, Yang CC. Predictors for outcome and treatment delay in patients with tuberculous meningitis. Am J Med Sci 2009; 338: 134-139.
13. Manfredi R, Moroni A, Mazzoni A et al. Isolated detection of cryptococcal polysaccharide antigen in cerebrospinal fluid samples from patients with AIDS. Clin Infect Dis 1996; 23: 849-850.
14. Hsieh CC, Lu JH, Chen SJ, Lan CC, Chow WC, Tang RB. Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis. Childs Nerv Syst 2009; 25: 461-465.
15. Libois A, De Wit S, Poll B et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34: 141-144.
16. Paemen L, Olsson T, Soderstrom M, Van Damme J, Opdenakker G. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur J Neurol 1994; 1: 55-63.
17. Yushchenko M, Weber F, Mäder M et al. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated concentrations are primarily related to CSF cell count. J Neuroimmunol 2000; 110: 244-251.
18. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998; 21: 75-80.
19. Miller A, Shapiro S, Lahat N, Galboiz Y. Matrix metalloproteinases and their inhibitors in brain injury and repair. In: Abramsky O, Comspton DAS, Miller A, Said G, eds, Brain disease: therapeutic strategies and repair. UK: Martin Dunitz, 2002; 63-68.
20. Sulik A, Chyczewski L. Immunohistochemical analaysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis. Folia Histochem Cytobiol 2008; 46: 437-442.
21. Keiseier BC, Seifert T, Giovannoni G, Hartung HP. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology 1999; 53: 20-25.
22. Gijbels K, Masure S, Carton H, Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 1992; 41: 29-34.
23. Sulik A, Wojtkowska M, Oldak E. Elevated level of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with Echovirus Type 30 and Mumps meningitis. Scand J Immunol 2008; 68: 323-327.
24. Kolb SA, Lahrtz F, Paul R et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol 1998; 84: 143-150.
25. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 1998; 152: 729-741.
26. Lee KY, Kim EH, Yang WS et al. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 2004; 220: 73-78.
27. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 13933-13938.
28. Cheung C, Luo H, Yanagawa B et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis. Cardiovasc Pathol 2006; 15: 63-74.
29. Bode W, Fernandez-Catalan C, Grams F et al. Insights into MMPTIMP interactions. Ann N Y Acad Sci 1999; 878: 73-91.